Pharmacologic treatment of cardiac arrest
| Autor: | Edward M. Racht, Peter J. Kudenchuk |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
Emergency Medical Services
medicine.medical_specialty Electric Countershock Amiodarone Emergency Nursing Pharmacological treatment Internal medicine Humans Medicine In patient cardiovascular diseases business.industry Pulseless ventricular tachycardia Advanced cardiac life support Lidocaine medicine.disease Heart Arrest Clinical trial Ventricular fibrillation cardiovascular system Emergency Medicine Cardiology business Anti-Arrhythmia Agents Life Support Systems medicine.drug |
| Zdroj: | Prehospital Emergency Care. 3:279-282 |
| ISSN: | 1545-0066 1090-3127 |
| DOI: | 10.1080/10903129908958954 |
| Popis: | Antiarrhythmic drugs currently recommended in the American Heart Association's Advanced Cardiac Life Support (ACLS) guidelines for the treatment of cardiac arrest have not been proved in controlled clinical trials to improve survival in patients with ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT). Intravenous amio-darone is a promising agent for the treatment of VF and VT. Based on available evidence, amiodarone should be considered for use in patients with shock-refractory ventricular arrhythmias. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|